Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emivirine in HIV-1 Infection
NCT00002413Phase 2Completed
- Sponsor
- Triangle Pharmaceuticals, Inc.
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of Emivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Triangle Pharmaceuticals, Inc. Primary endpoints: Safety and Tolerability as Assessed by Adverse Events and Change in Plasma HIV-1 RNA. Status: completed.
02
Drugs
Emivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00002413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002413.